Long-term follow-up in AIDS clinical trials

Area of Science:

• Clinical Trials Methodology
• Epidemiology of Infectious Diseases
• Biostatistics in Medical Research

Background:

• Follow-up strategies in AIDS clinical trials vary significantly.
• Current methods include data collection only until protocol therapy cessation or until disease progression/study end.
• Extended follow-up post-therapy is being considered for specific trial scenarios.

Purpose of the Study:

• To evaluate the impact of different patient follow-up strategies on the conclusions drawn from AIDS clinical trials.
• To analyze the effect of collecting data after protocol therapy cessation.
• To formalize the relationship between primary and secondary endpoints in trial analysis.

Main Methods:

• The study employs simulation methods to model various follow-up strategies.
• Operating characteristics of strategies with primary and secondary endpoints are calculated.
• The influence of post-therapy data collection on trial outcomes is assessed.

Main Results:

• Simulations demonstrate that follow-up strategies significantly affect trial conclusions.
• Extended follow-up can alter the interpretation of treatment efficacy.
• The interplay between primary and secondary endpoints is crucial for robust analysis.

Conclusions:

• The choice of follow-up strategy in AIDS clinical trials is critical and influences study outcomes.
• Implementing extended follow-up requires careful consideration of its impact on data interpretation.
• Formalizing the support or contradiction between primary and secondary analyses enhances trial validity.